2025-04-10 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis

**0. Overview:**

Intuitive Surgical Inc. is a leading developer and manufacturer of robotic-assisted surgery systems, primarily the da Vinci Surgical System.


**1. Performance Comparison and Divergence:**

* **ISRG Cumulative Return:** 121.94%
* **VOO (S&P 500) Cumulative Return:** 66.94%
* **Return Difference:** 55.00% (ISRG outperformed VOO by 55 percentage points)
* **Relative Divergence:** 48.1% (This indicates ISRG's performance is in the higher range of its historical performance relative to the S&P 500, based on the provided min/max range).


The table below shows the Compound Annual Growth Rate (CAGR), Maximum Drawdown (MDD), Alpha, Beta, and market capitalization (Cap) for ISRG over various periods.  A higher CAGR indicates stronger growth.  MDD shows the largest percentage drop from peak to trough. Alpha measures excess return compared to the benchmark, while Beta measures volatility relative to the benchmark.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 56.5% | 38.0% | 0.0 | 43.6 |
| 2016-2018  | 77.0% | 63.4% | 60.0% | 0.0 | 57.2 |
| 2017-2019  | 81.0% | 63.4% | 52.0% | 0.3 | 70.6 |
| 2018-2020  | 47.0% | 63.4% | 22.0% | 0.2 | 97.7 |
| 2019-2021  | 91.0% | 63.0% | 37.0% | 0.3 | 128.7 |
| 2020-2022  | -3.0% | 69.9% | -9.0% | 0.3 | 95.1 |
| 2021-2023  | -5.0% | 72.9% | -22.0% | 1.0 | 120.9 |
| 2022-2024  | 26.0% | 72.9% | 9.0% | 1.0 | 187.0 |
| 2023-2025  | 43.0% | 72.9% | 28.0% | 0.6 | 187.4 |

**Analysis of the Table:**  ISRG shows consistently high CAGRs, except for the 2020-2022 and 2021-2023 periods.  The high Beta values in the last two years suggest increased volatility.  Alpha values fluctuate but generally indicate outperformance, particularly in earlier periods.  Market capitalization increased significantly over time.


**2. Recent Price Movement:**

* **Closing Price:** $522.95
* **5-Day Moving Average:** $478.08
* **20-Day Moving Average:** $491.83
* **60-Day Moving Average:** $546.84

**Analysis:** The closing price is above the 5-day and 20-day moving averages, suggesting a potential upward trend. However, it's below the 60-day moving average, indicating a possible short-term correction within a longer-term upward trend.  The significant daily change of $14.27 (from previous close) points to a recent substantial price increase.

**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.5289 (High Risk)
* **RSI:** 57.41 (Slightly above neutral; not overbought)
* **PPO:** 0.36 (Positive, suggesting upward momentum)
* **20-Day Relative Divergence Change:** -5.7% (Short-term downward pressure)
* **Expected Return (2+ years):** 41.4% (Significant expected outperformance of the S&P 500)

**Analysis:** The high MRI suggests caution. While RSI and PPO indicate a relatively positive trend, the recent negative relative divergence indicates some short-term weakness.  The significant price increase needs to be considered in the analysis; the rapid price surge might indicate a temporary overbought condition. The high expected return is very promising, although it assumes continued long-term positive growth.

**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-18 | $1.59 | $2.04 B     |
| 2024-07-19 | $1.48 | $2.01 B     |
| 2024-04-19 | $1.54 | $1.89 B     |
| 2023-10-20 | $1.18 | $1.74 B     |
| 2024-10-18 | $1.18 | $1.74 B     | *(Duplicate entry, likely a data error)*


**Analysis:**  There's a possible error in the data (duplicate entry).  Excluding the duplicate, revenue shows a slight increase in the last two quarters. EPS fluctuates, but generally shows improvement. More data would be needed for a comprehensive analysis.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |
| 2024-06-30 | $2.01B | 68.30% |
| 2024-03-31 | $1.89B | 65.87% |
| 2023-12-31 | $1.93B | 66.24% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |


**Analysis:** Revenue and Profit margins are generally high and stable, demonstrating the company's strong profitability. Equity is growing steadily, but ROE shows some fluctuation.

**6. Overall Analysis:**

ISRG has demonstrated significantly higher returns than the S&P 500 over the long term.  While recent indicators suggest some short-term risk and potential for a correction, the long-term outlook appears promising, supported by high profit margins, growing revenue, and a substantial projected long-term return.  However, the high Market Risk Indicator suggests caution is warranted, and careful monitoring of the market conditions is crucial before making any investment decisions.  The high projected return is based on several assumptions; further independent research is necessary.  Data inconsistencies and the lack of sufficient historical data, in certain sections, limit the scope of this analysis.  Consider additional due diligence before making investment decisions.
